2026-01-13 - Analysis Report
**Report Overview**
=====================

Lam Research Corp (LRCX) is a leading provider of semiconductor manufacturing equipment.

**Cumulative Return Comparison**
------------------------------

| Stock | Cumulative Return |
|-------|--------------------|
| LRCX  | 310.29%            |
| VOO   | 94.34%             |

The cumulative return of LRCX is significantly higher than the S&P 500 index (VOO).

**Divergence Analysis**
----------------------

* Divergence (max: 212.50, min: -14.70, current: 212.50, relative divergence: 100.00%)

The current divergence is at the upper end of the historical range.

**Alpha, Beta Analysis**
------------------------

| Year | CAGR | MDD | Alpha | Beta | Cap(B) |
|------|------|-----|-------|------|--------|
| 2016-2018 | 1.0% | 34.2% | -2.0% | 1.6  | 17.2B  |
| 2017-2019 | 38.0% | 34.2% | 21.0% | 1.7  | 36.9B  |
| 2018-2020 | 57.0% | 34.2% | 36.0% | 1.5  | 59.5B  |
| 2019-2021 | 105.0% | 24.5% | 62.0% | 1.6  | 90.7B  |
| 2020-2022 | -11.0% | 49.0% | -9.0% | 1.6  | 53.0B  |
| 2021-2023 | -14.0% | 49.0% | -15.0% | 1.8  | 98.8B  |
| 2022-2024 | -47.0% | 42.4% | -66.0% | 1.9  | 91.1B  |
| 2023-2025 | 150.0% | 43.7% | 88.0% | 2.0  | 215.9B |

* The company has shown significant growth in CAGR, with a maximum CAGR of 150.0% in 2023-2025.

**Recent Stock Price Fluctuations**
-----------------------------------

|  | Value |
| --- | --- |
| Close | $220.40 |
| 5-day SMA | $209.95 |
| 20-day SMA | $181.81 |
| 60-day SMA | $163.71 |

* The 5-day and 20-day SMAs are below the current close price.

**RSI, PPO Analysis**
----------------------

| Indicator | Value |
| --- | --- |
| RSI | 82.47 |
| PPO | 2.01 |

* The RSI is at an extremely high level (above 80).

**Delta_Previous_Relative_Divergence and Expected_Return**
--------------------------------------------------------

| Indicator | Value |
| --- | --- |
| Hybrid Signal | Buy |
| Risk Level | Medium |
| 7-day Rank change | -1 |
| 7-day Dynamic Expected Return change | 0.10 |
| Expected Return (%) | 11.10% |

* The stock is considered a buy with a high expected return.
* The expected return is 11.10%.

**Recent News & Significant Events**
-----------------------------------

* [2026-01-09] Why Is Lam Research (LRCX) Stock Soaring Today - Yahoo Finance
* [2026-01-12] What Could Keep Driving Lam Research Stock Higher? - Forbes
* [2026-01-13] Assessing Whether Lam Research (LRCX) Looks Overvalued After Its Strong Recent Share Price Run - simplywall.st

**Analyst Opinions**
---------------------

* **Analyst Consensus:**
  + **Key:** Buy
  + **Mean (1=StrongBuy~5=Sell):** 1.77 (~Buy)
  + **Opinions:** 30
  + **Target Price (avg/high/low):** 181.13 / 265.00 / 115.00

**Recent Earnings Analysis**
---------------------------

| Date | EPS | Revenue |
| --- | --- | --- |
| 2025-10-24 | 1.24 | 5.32 B$ |
| 2025-04-25 | 1.04 | 4.72 B$ |
| 2025-01-31 | 0.93 | 4.38 B$ |
| 2024-10-28 | 0.86 | 4.17 B$ |
| 2025-10-24 | 0.86 | 4.17 B$ |

* EPS has increased in the past few quarters.
* Revenue has also increased, with a maximum revenue of 5.32 B$ in 2025-10-24.

**Revenue and Profitability**
---------------------------

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $5.32B | 50.43% |
| 2025-06-30 | $5.17B | 50.08% |
| 2025-03-31 | $4.72B | 49.02% |
| 2024-12-31 | $4.38B | 47.37% |
| 2024-09-30 | $4.17B | 48.05% |

* Revenue has increased in the past few quarters.
* Profit margin has been fluctuating, with a maximum profit margin of 50.43% in 2025-09-30.

**Capital and Profitability**
---------------------------

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $10.19B | 15.39% |
| 2025-06-30 | $9.86B | 17.44% |
| 2025-03-31 | $9.51B | 13.99% |
| 2024-12-31 | $8.81B | 13.52% |
| 2024-09-30 | $8.47B | 13.18% |

* Equity has increased in the past few quarters.
* ROE has been fluctuating, with a maximum ROE of 17.44% in 2025-06-30.

**Comprehensive Analysis**
---------------------------

Based on the analysis of the company's financial performance, market data, and recent news, we conclude:

* The company has shown significant growth in CAGR and revenue.
* EPS and equity have increased in the past few quarters.
* The stock is considered a buy with a high expected return.
* Profit margin and ROE have been fluctuating.
* The company's financial performance is strong, but the stock price may be overvalued.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.